Management of hepatic metastases from colorectal cancer

Clinics in Colon and Rectal Surgery

Volumn 18, Issue 3, 2005, Pages 215-223

  Sheth, Ketan R ^a   Clary, Bryan M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Colorectal cancer; Hepatic ablation; Hepatic metastases; Hepatic resection

Indexed keywords

BEVACIZUMAB; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

BILIARY TRACT DISEASE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SURGERY; CLINICAL TRIAL; COLORECTAL CANCER; HEPATIC ARTERY; HUMAN; INFUSION PUMP; LIVER METASTASIS; LIVER RESECTION; RADIOFREQUENCY ABLATION; REVIEW; RISK ASSESSMENT; SCLEROSIS; SIDE EFFECT; SURGICAL TRAINING; TECHNOLOGY; UNITED STATES;

EID: 24344463892     PISSN: 15310043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-916282     Document Type: Review

References (58)

1. Jemal A, Thomas A, Murray T, et al. Cancer statistics. CA Cancer J Clin 2002;52:23-47
2. Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 1969;23:198-202
3. Cady B, Monson D, Swinton N. Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg Gynecol Obstet 1970;131:697-700
4. Scoggins C, Meszoely I, Blanke C, et al. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 1999;6:651-657
5. Ohlsson B, Tranberg K, Lundstedt C, et al. Detection of hepatic metastases in colorectal cancer: a prospective study of laboratory and imaging methods. Eur J Surg 1993;159:275-281
6. Finlay I, McArdle CS. Occult hepatic metastases in colorectal carcinoma. Br J Surg 1986;73:732-735
7. Lefor A, Hughes K, Shiloni E, et al. Intra-abdominal extrahepatic disease in patients with colorectal hepatic metastases. Dis Colon Rectum 1988;31:100-103
8. Ries L, Miller B, Hankey B, et al. SEER Cancer Statistics Review, 1973-1991: Tables and Graphs. Report no. NIH-94-2789. Bethesda, MD: National Cancer Institute; 1994
9. Jessup J, McGinnis L, Steele GJ, et al. The national cancer data base report on colon cancer. Cancer 1996;78:918-926
10. Moertel C, Fleming T, MacDonald J, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 1995;122:321-326
11. Shelton A, Wong W. Colorectal cancer. In: Cameron J, ed. Current Surgical Therapy. St. Louis: Mosby; 1998:217-227
12. Martin R, Paty P, Fong Y, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 2003;197:233-242
13. Blumgart LH, Allison DJ. Resection and embolization in the management of secondary hepatic tumors. World J Surg 1982; 6:32-45
14. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230:309-318
15. Fong Y, Blumgart LH. Hepatic colorectal metastases: current status of surgical therapy. Oncology 1998;12:1489-1498
16. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938-946
17. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 1990;77:1241-1246
18. Wagner J, Adson M, van Heerden J, et al. The natural history of hepatic metastases from colorectal cancer. Ann Surg 1984;199:502-508
19. Rougier P, Milan C, Lazorthes F, et al. Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Br J Surg 1995;82:1397-1400
20. Lahr C, Soong S, Cloud G, et al. A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol 1983;1:720-725
21. Wood C, Gillis C, Blumgart L. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976;2:285-288
22. Pestana C, Reitemeier R, Moertel C, et al. The natural history of carcinoma of the colon and rectum. Am J Surg 1964;108: 826-829
23. Welch J, Donaldson G. The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 1979;189:496-502
24. Gilbert H, Kagan A. Metastases: incidence, detection, and evaluation without histologic confirmation. In: Weiss L, ed. Fundamental Aspects of Metastasis. Amsterdam: North-Holland Publishing; 1976:385-405
25. Scheele J, Stang R, Atendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19:59-71
26. Moran B, O'Rourke N, Plant G, Rees M. Computed tomographic portography in preoperative imaging of hepatic neoplasms. Br J Surg 1995;82:669-671
27. McDermott V, Lawrance J, Paulson E, et al. CT during arterial portography: comparison of injection into the splenic versus superior mesenteric artery. Radiology 1996;199:627-631
28. Fernandez FG, Drebin JA, Linehan DC, et al. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose(FDG-PET). Ann Surg 2004; 240:438-450
29. Soyer P, Levesque M, Elias D. Detection of liver metastases from colorectal cancer: comparison of intraoperative ultrasound and CT during arterial portography. Radiology 1992; 183:541-544
30. Cordon R, Jacobs M, Dasgupta D, et al. The value of intraoperative ultrasound during hepatic resection compared with improved preoperative MRI. Eur J Ultrasound 2003; 16:211-216
31. Grobmyer SR, Fong Y, D'Angelica M, et al. Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases. Arch Surg 2004;139:1326-1330
32. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. Nordic Gastrointestinal Tumor Adjuvant Therapy Group. J Clin Oncol 1992;10:904-911
33. Scheithauer W, Rosen H, Kornek G, et al. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 1993;306:752-755
34. Saltz L, Shimada Y, Khayat D. CPT-11 (irinotecan) and 5-fluorouracil: a promising combination for therapy of colorectal cancer. Eur J Cancer 1996;32A(suppl 3):S24-S31
35. Adam R. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol 2003;14:13-16
36. Leonard GD, Brenner B, Kemeny N. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2005; 23:2038-2048
37. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-2342
38. Hamady ZZ, Kotru A, Nishio H, et al. Current techniques and results of liver resection for colorectal liver metastases. Br Med Bull 2004;70:87-104
39. Elias D, Oullet JF, De Baere T, et al. Pre-operative selective portal vein embolization before hepatectomy for liver metastases. Surgery 2002;131:294-299
40. Adam R, Laurent A, Azoulay D, et al. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 2000;232:777-785
41. Minagawa M, Makuuchi M, Torzilli G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000;231:487-499
42. Ambiru S, Miyazaki M, Isono T, et al. Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum 1999;42:632-639
43. Jamison R, Donohue J, Nagorney D, et al. Hepatic resection for metastatic colorectal cancer results in cure for some. Arch Surg 1997;132:505-511
44. Gayowski T, Iwatsuki S, Madariaga J, et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 1994;116:703-711
45. Doci R, Bignami P, Montalto F, Gennari L. Prognostic factors for survival and disease-free survival in hepatic metastases from colorectal cancer treated by resection. Tumori 1995;81(3 suppl):143-146
46. Jaeck D, Bachellier P, Guiguet M, et al. Survival benefit of repeat liver resection for recurrent colorectal metastases: 143 cases. Wiad Lek 1997;50(suppl 1):102-104
47. Fong Y, Blumgart L, Cohen A, et al. Repeat hepatic resections for metastatic colorectal cancer. Ann Surg 1994; 220:657-662
48. Fernandez-Trigo V, Shamsa F, Sugarbaker P. Repeat liver resections from colorectal metastasis. Repeat Hepatic Metastases Registry. Surgery 1995;117:296-304
49. Petrowsky H, Gonen M, Jarnigan W, et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg 2002;235:863-871
50. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002;235:759-766
51. Ng KK, Poon RT. Radiofrequency ablation for malignant liver tumor. Surg Oncol 2005;14:41-52
52. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239:818-827
53. Wood TF, Rose DM, Chung M, et al. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limits, and complications. Ann Surg Oncol 2000;7:593-600
54. Bowles BJ, Machi J, Limm WML, et al. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg 2001;136:864-869
55. Curley SA, Izzo F, Ellis LM, et al. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000;232:381-391
56. Barber FD, Mavligit G, Kurzock R. Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview. Cancer Treat Rev 2004;30:425-436
57. Onaitis M, Morse M, Hurwitz H, et al. Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastases. Ann Surg 2003;237:782-788
58. Martin RC, Edwards MJ, McMasters KM. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver. Am J Surg 2004;188:714-721